Cervical Cancer Clinical Trials

According to the American Cancer Society, in 2020, about 13,800 new cases of invasive cervical cancer will be diagnosed in the US, and 4,290 women will die from cervical cancer. Most cases of cervical cancer are caused by the Human Papillomavirus (HPV), but regular screening can be helpful with cancer prevention. The increased use of the Pap test has decreased the death rate of women with cervical cancer because it helps with early detection. The HPV test can also help with screening for cervical cancer. As a cancer that is frequently diagnosed in younger women aged 35-44, it often comes as a challenging surprise. Surprises can be less of a challenge when you arm yourself with Massive Bio’s assistance.

Massive Bio’s number one priority is to create positive outcomes for cancer patients. With the Clinical Trial Matching Service and Virtual Tumor Board, you are one-step closer to reaching that positive outcome.

Cancer clinical trials are important for cancer treatment; they find and prove new ways to fight cancer. By participating in a clinical trial, you can find the best treatment for your cervical cancer and help others who are struggling with cervical cancer. Getting access to the right clinical trials and right treatments shouldn’t have to be overwhelming. That’s why Massive Bio uses the clinical trial matching service to match cervical cancer patients to the right clinical trials based on the stage of disease, biomarker status, geographical location and past medical history.